Clinical trial · Interventional
Comparison of DNA Ploidy and Conventional Cytology
A Prospective Comparison of Digital Image Analysis and Routine Cytology for the Identification of Pancreatic Neoplasia in Patient Undergoing EUS-FNA
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
150 patients who had suspected pancreatic malignancy were planed to be enrolled in this study. Equal cytological samples of each patient undergoing EUS-FNA were examined by digital image analysis and conventional cytology respectively. The investigators aim to compare the efficacy of DIA and conventional cytology in diagnosing pancreatic cancer. Further more, the investigators also collected the blood sample of each enrolled patient for advanced study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biopsy, Fine-Needle | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cytology | Procedure | — | UNRESOLVED |
| DNA ploidy | Procedure | — | UNRESOLVED |
| EUS-FNA | Procedure | — | UNRESOLVED |
| EUS-guided fine needle | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Conventional cytology
- description
- Patients in this arm will undergo an operation of EUS-FNA . The acquired cytological samples from EUS-FNA will undergo a conventional cytology.
- interventionNames
- Procedure: cytology
- Procedure: EUS-FNA
- Device: EUS-guided fine needle
- type
- OTHER
- label
- DNA ploidy test
- description
- Patients in this arm will undergo an operation of EUS-FNA . The acquired cytological samples from EUS-FNA will undergo DNA ploidy test.
- interventionNames
- Procedure: DNA ploidy
- Procedure: EUS-FNA
- Device: EUS-guided fine needle
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: 1. who had known or suspected pancreatic malignancy and 2. in whom the endosonographer deemed the target lesion safe and feasible to allow the necessary study passes. Exclusion Criteria: 1. not willing to sign informed consent, 2. cells obtained from FNA for DNA ploidy test less than 200, and/or 3. patients do not cooperate with follow-up.
References
Publications (0)
Data not yet available